KDM6A and hepatocellular carcinoma: Our findings indicate that KDM6A overexpression significantly alters several cancerous characteristics and promotes hepatocytic differentiation, suggesting its potential as a noninvasive molecular therapeutic target to prevent metastasis and recurrence rate in HCC.